Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at new ways to improve treatment for prostate cancer that has spread (STAMPEDE2)

Overview

Cancer types:

Prostate cancer, Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is looking at adding certain treatments to hormone treatment for prostate cancer that has spread to other parts of the body.

Cancer Research UK supports this trial.

Recruitment start: 1 June 2024

Recruitment end: 1 January 2030

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Nick James  Professor Gert Attard

Supported by

University College London

Medical Research Council (MRC) Clinical Trials Unit at UCL

Cancer Research UK

Medical Research Council

Advanced Accelerator Applications (ADACAP) Novartis

Johnson & Johnson (provided funding during trial setup period)

Other information

There is more information about the trial on the STAMPEDE2 trial website(link is external).

Last reviewed: 14 Mar 2025

CRUK internal database number: 19502

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.